Paper7797604
Formestane: an effective first-line endocrine treatment for advanced breast cancer.
Zilembo N and 9 others. J Cancer Res Clin Oncol, 1995. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Formestane: an effective first-line endocrine treatment for advanced breast cancer. Papers, record 7797604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7797604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Androstenedione | Major topic |
| Antineoplastic Agents | Major topic |
| Aromatase Inhibitors | Major topic |
| Breast Neoplasms | Major topic |
| 17-Hydroxycorticosteroids | |
| Aged | |
| Drug Administration Schedule | |
| Estradiol | |
| Female | |
| Humans | |
| Injections, Intramuscular | |
| Middle Aged | |
| Postmenopause | |
| Prognosis | |
| Risk Factors | |
| Survival Analysis | |
| Treatment Outcome |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2900646 | Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party. | Br J Cancer | 1988 | https://conductscience.org/library/papers/2900646 | PubMed |
| 2 | 1498070 | Towards a molecular basis for tamoxifen resistance in breast cancer. | Ann Oncol | 1992 | https://conductscience.org/library/papers/1498070 | PubMed |
| 3 | 3061640 | Antioestrogens in the management of hormone-dependent cancer. | Cancer Treat Rev | 1988 | https://conductscience.org/library/papers/3061640 | PubMed |
| 4 | 1995354 | A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patients. | Eur J Surg Oncol | 1991 | https://conductscience.org/library/papers/1995354 | PubMed |
| 5 | 7873457 | Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer. | Ann Oncol | 1994 | https://conductscience.org/library/papers/7873457 | PubMed |
| 6 | 2644532 | A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. | N Engl J Med | 1989 | https://conductscience.org/library/papers/2644532 | PubMed |
| 7 | 7507033 | Tamoxifen as adjuvant therapy in breast cancer. Current status. | Drugs | 1993 | https://conductscience.org/library/papers/7507033 | PubMed |
| 8 | 2885637 | Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. | Lancet | 1987 | https://conductscience.org/library/papers/2885637 | PubMed |
| 9 | 6851305 | Primary treatment of breast cancer in elderly women with Tamoxifen. | Clin Oncol | 1983 | https://conductscience.org/library/papers/6851305 | PubMed |
| 10 | 8018527 | Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8018527 | PubMed |
| 11 | 912660 | Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. | Cancer | 1977 | https://conductscience.org/library/papers/912660 | PubMed |
| 12 | 2259926 | Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program. | Semin Oncol | 1990 | https://conductscience.org/library/papers/2259926 | PubMed |
| 13 | 2322991 | Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2322991 | PubMed |
| 14 | 2144154 | Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. | Eur J Cancer | 1990 | https://conductscience.org/library/papers/2144154 | PubMed |
| 15 | 3917820 | Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3917820 | PubMed |
| 16 | 3123050 | Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. | Cancer Res | 1988 | https://conductscience.org/library/papers/3123050 | PubMed |
| 17 | 2900647 | Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation. | Br J Cancer | 1988 | https://conductscience.org/library/papers/2900647 | PubMed |
| 18 | 7902904 | Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. | Lancet | 1993 | https://conductscience.org/library/papers/7902904 | PubMed |
| 19 | 1531483 | The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects. | J Clin Endocrinol Metab | 1992 | https://conductscience.org/library/papers/1531483 | PubMed |
| 20 | 1419285 | 4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer. | Eur J Cancer | 1992 | https://conductscience.org/library/papers/1419285 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP19A1 | 1588 | PubTator's text mining | https://conductscience.org/library/genes/1588 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7797604
GET https://conductscience.org/api/papers/v1/7797604/references?page=2